Telomerase is a specialized reverse transcriptase that extends telomeres of eukaryotic chromosomes. The catalytic core of human telomerase is composed of an RNA template known as hTER (human telomerase RNA) and a protein subunit named hTERT (human telomerase reverse transcriptase). We have been studying other functions of the telomerase besides its major role in telomere maintenance. In our previous work, we have demonstrated that the hTERT can functionally interact with a rabbit TER to regulate expression of other genes and also attenuate the induced apoptosis. Here we report that overexpression of hTERT in a human lens epithelial cell line accelerates growth of the transfected lens epithelial cells. Associated with the acceleration of cell growth, expression of p53, p21 and GCIP (Grap2 cyclin-D interacting protein) is downregulated in the hTERTtransfected cells. With the downregulation of p21 and GCIP, the retinoblastoma protein (RB) is completely hyperphosphorylated in the hTERT-transfected cells. As expected, in the presence of RB hyperphosphorylation, the E2F transactivity is upregulated. Inhibition of telomerase activity abolishes the observed growth acceleration and also the related molecular changes. Furthermore, expression of hTERT in telomerasenegative human lens epithelial cells derived from primary cultures also accelerates growth of the transfected cells. Taken together, our results suggest that hTERT, when overexpressed in human lens epithelial cells, accelerates cell growth rate through regulation of RB/E2F pathway and possibly other genes.
Telomerase is a specialized reverse transcriptase that extends telomeres of eukaryotic chromosomes (Greider and Blackburn, 1985 ; reviewed by Greider, 1996; Collins, 2000) . The catalytic core of human telomerase is composed of an RNA subunit known as hTER (human telomerase RNA) and a protein subunit named as hTERT (human telomerase reverse transcriptase) (Feng et al., 1995; Greider, 1996; Nakamura et al., 1997; Collins, 2000) . Expression of hTERT is a key step of activation of telomerase in human cells and plays a crucial role in cellular immortalization and cancer development (Meyerson et al., 1997; Bodnar et al., 1998; Klingelhutz, 1999; Meyerson, 2000) . Several studies indicate that various genes are implicated in regulation of telomerase activity directly or indirectly. These genes include c-myc, mad1, bcl-2, p53, p21 WAF1 , RB, PKC and protein phosphatase 2A (Liu, 1999; Gunes et al., 2000) . However, how telomerase aects the expression of other genes is still unclear. Recent studies suggest that, besides its major role in telomere maintenance, telomerase may also interact with nontelomeric DNA (Magnenat et al., 1999) and other molecules such as signaling protein p53 (Li et al., 1999) . Our previous work demonstrates that hTERT can regulate expression of other genes including c-jun, c-fos, p53 and bcl-Xs, and also prevent camptothecininduced apoptosis in rabbit lens epithelial cells (Xiang et al., 2000) . It is conceivable that through interactions with other molecules, telomerase may exert dierent functions besides its major role in maintaining the stability of telomere structures.
In this study, we report that overexpression of telomerase in a human lens epithelial cell line (HLE) as well as in human lens epithelial cells derived from primary cultures accelerates cell growth, and the possible mechanism underlying this cell growth regulation is also investigated. The human lens epithelial cell line used in this study is immortalized from primary cultures through transfection with a plasmid containing the gene encoding simian virus 40 large-T antigen (SV40-TAg) (Ibaraki et al., 1998) . Although SV40-TAg is well known to interact with tumor suppressor proteins p53 and RB, and therefore may disable their normal cellular signaling pathways in immortalized cells (Chen et al., 1992; Bryan and Reddel, 1994 ), a number of recent studies have demonstrated that, in SV40-Tag-transformed murine and human cells, p53 is still functional in responses to DNA damage (Hess and Brandner, 1997; Kohli and Jorgensen, 1999) . Our present study also reveals that p53 and Rb are not completely inactivated by SV40-TAg in HLE cells. These molecules seem to mediate the telomeraseaccelerated cell growth in these cells. Since the HLE is an immortalized cell line and has endogenous telomerase activity, we further con®rmed our observation by introducing the hTERT cDNA into telomerase negative human lens epithelial cells, which are derived from primary cultures of the donated human lenses. In this communication, we will present data to show the following: First, the hTERT, when overexpressed in the immortalized human lens epithelial cells (HLE) and the telomerase negative human lens epithelial cells derived from primary cultures (HLEPC), accelerates cell growth rate. Secondly, in the HLE cells, overexpression of hTERT downregulates expression of p53, p21 and GCIP (Grap2 cyclin-D interacting protein). Moreover, overexpression of GCIP in pCI-hTERT-HLE cells substantially slows down the growth rate of the double-transfected cells. Thirdly, the overexpressed hTERT also enhances the hyperphosphorylation of RB and upregulates E2F transactivity. Finally, inhibition of hTERT activity in HLE abolishes the accelerated growth rate and also the related molecular changes. We suggest that hTERT accelerates cell growth rate of HLE through RB/E2F pathway and of course, our results do not rule out that other genes may be involved in this growth control as well.
To overexpress hTERT in HLE cells, we introduced the hTERT expression plasmid pCI-neo-hTERT (Kolquist et al., 1998) and its parallel control vector pCIneo (Xiang et al., 2000) into HLE cells by electroporation. After 6-week's selection with G418 (400 mg/ml), we established hTERT overexpression cell line, pCIhTERT-HLE and vector-transfected cell line, pCI-HLE. RT ± PCR results showed that hTERT gene was overexpressed about threefold at the mRNA level in the pCI-hTERT-HLE cells compared with the vector-transfected pCI-HLE cells and their parental HLE cells (Figure 1a,b) . The hTERT activity was also increased in pCI-hTERT-HLE cells as determined by TRAP assay (Figure 1c ). During our establishment of the pCI-hTERT-HLE and pCI-HLE cell lines, one phenotype displayed by pCI-hTERT-HLE was that these cells grew clearly faster than pCI-HLE cells. To conduct quantitative analysis on this phenotype, we compared the cell growth rate of these two types of transfected cells using the established stable cell lines, which showed dierent hTERT levels ( Figure 1c ). An equal number (8610 4 ) of pCI-hTERT-HLE and pCI-HLE cells were seeded in six-well culture plates and their growth rates were analysed through counting the cell number in each culture well every 24 h. As shown in Figure 1e , after a 4-day growth, while pCI-hTERT-HLE cells reached 100% con¯uence, the pCI-HLE cells were just about 50% con¯uent. Similar results were obtained in our repeated experiments. In contrast, when the growth rate was compared between pCI-HLE and the parental HLE cells (at the same population doubling time when hTERT was introduced into this line), little dierence was detected (data not shown). Since the vector-transfected HLE and the parental HLE had no dierence in their telomerase activity ( Figure 1c ) and growth rate, our subsequent experiments excluded the parental HLE. To con®rm that the observed acceleration of cell growth is derived from overexpression of hTERT in HLE, we treated both vector-and hTERT-transfected HLE with a telomerase inhibitor, a hexameric oligonucleotide, 5'-d(TTAGGG)-3' or a control oligonucleotide, 5'-d(TGTGAG)-3'. Previous studies have established that the 5'-d(TTAGGG)-3' oligonucleotide is eective in inhibiting telomerase activity in several dierent types of cells in culture (Morin, 1989; Mata et al., 1997; Fu et al., 1999) . As shown in Figure 1d , while 20 mM of 5'-d(TTAGGG)-3' was able to substantially inhibit telomerase activity in both pCI-HLE and pCIhTERT-HLE cells, the control oligonucleotide had little eect. Under these conditions, the cell growth rate was compared between vector-and hTERT-transfected cells with or without inhibitor treatment and the results were shown in Figure 1e . As expected, the cell proliferation was distinctly slowed down when telomerase activity was inhibited in pCI-HLE and pCIhTERT-HLE cells (Figure 1e ), a result similar to that observed in Burkitt's lymphoma cells (Mata et al., 1997) .
We next investigated the possible mechanism mediating the acceleration of cell growth in hTERToverexpressed pCI-hTERT-HLE cells. It is widely recognized that the retinoblastoma tumor suppressor protein RB and the members of the transcription factor E2F family are key regulators of cell proliferation (Dyson, 1998; Lania et al., 1999; Muller et al., 2001) . Hypophosphorylated RB suppresses cell growth in part by functional interaction with E2F family members. But hyperphosphorylated RB, on the other hand, releases E2F transcription factors that can regulate a series of genes whose products are essential for cell growth (Helin, 1998; Muller et al., 2001) . So in this investigation we ®rst detected the RB phosphorylation status with Western blot analysis. The protein extracts were prepared from cultures of pCI-hTERT-HLE, and its mock control, pCI-HLE cells, at the close cell density (about 95% con¯uence), and equivalent amounts (100 mg) of these two samples were subjected to 6% SDS ± PAGE. Western blot results revealed distinct dierence regarding the phosphorylation status of RB between the two samples ( Figure 2a ), while there was little change in the total amount of RB proteins in these samples. In pCI-hTERT-HLE cells, almost all of the RB protein was hyperphosphorylated. In contrast, only 60% of RB proteins were hyperphosphorylated in pCI-HLE cells. In the telomerase inhibitor-treated pCIhTERT-HLE cells, a similar level of RB hyperphosphorylation was observed as that in pCI-HLE cells. Thus, our results suggest that expression of the Oncogene Telomerase accelerates cell growth H Xiang et al Figure 1 Overexpression of hTERT in HLE cells accelerates cell growth, and inhibition of hTERT activity abolishes the growth acceleration. (a) RT ± PCR to detect the mRNA expression of the hTERT. Total RNA was extracted with Trizol Reagent (Life Technologies, Inc), and 2 mg of total RNA was used for reverse transcription in a 20-ml reaction with Superscript II (Life Technologies, Inc) according to manufacture's protocol. Two ml of the reverse transcripts were used for semiquantitative RT-PCR with b-actin as internal control in each reaction. The primers used in this study are 5'-GTGGGGCGCCCCAGGCACCA-3' (forward) and 5'-CTCCTTAATGTCACGCACGATTTC-3' (reverse) for b-actin gene; 5'-GCTGATGAGTGTGTACGTCG-3' (forward) and 5'-CTCTTTTCTCTGCGGAACGT-3' (reverse) for hTERT gene. PCR was run four cycles with hTERT primers before b-actin primers were added for another 30 cycles. (b) Quantitation of the RT ± PCR results in (a) to show that the hTERTtransfected human lens epithelial cells (pCI-hTERT-HLE) contain a threefold higher hTERT mRNA than vector-transfected human lens epithelial cells (pCI-HLE) and non-transfected human lens epithelial cells (HLE). The DNA band of 309-bp (the bottom row) is ampli®ed from hTERT mRNA. The top is the internal control DNA band of 540-bp ampli®ed from the b-actin mRNA. (c) Assay of hTERT activity. Cell extracts were prepared in 16CHAPS lysis buer (Intergen, Inc), and telomerase activity was detected by the PCR-based telomeres repeat ampli®cation protocol (TRAP) and quantitated using an internal control as described before (Xiang et al., 2000) . Note that the expressed hTERT displays elevated telomerase activity in pCI Since the RB phosphorylation status was clearly dierent between pCI-HLE and pCI-hTERT-HLE, we predicted that there may be dierence in E2F activity. As described early, the HLE cells we used contain the SV40-TAg. If the SV40-TAg completely inactivates RB in these cells, we may not be able to detect change of E2F activity in the two types of cells since all of the E2F factors were supposed to be`free' regardless of the RB phosphorylation status. However, if RB proteins were not completely blocked by SV40-TAg, the observed change of RB phosphorylation status would lead to dierent E2F activity. There should be more cells were pre-treated for 48 h with 20 mM of the two oligonucleotides after they grew into 80% con¯uence. Then, these treated cells were passaged into new dishes containing 20 mM of 5'-d(TTAGGG)-3' (pCI-HLE+1 and pCI-hTERT-HLE+1) or the control oligonucleotide 5'-d(TGTGAG)-3' (pCI-HLE+2 and pCI-hTERT-HLE+2) in their culture media for another 4-day growth. By the end of the treatment, both pCI-HLE and pCI-hTERT-HLE cells were either harvested for TRAP assay as described in c or used for analysis of growth rate (described below). (e). Analysis of growth rate of pCI-HLE and pCI-hTERT-HLE cells, or the two types of cells treated with 5'-d(TTAGGG)-3' (pCI-HLE+1 and pCI-hTERT-HLE+1), or with the control oligonucleotide 5'-d(TGTGAG)-3' (pCI-HLE+2 and pCI-hTERT-HLE+2). Both pCI-HLE and pCI-hTERT-HLE cells with or without treatment were plated in 6-well plates at 8610 4 cells per well. The media in the absence or presence of 20 mM of the two oligonucleotides were replaced every 2 days, and the cells of pCI-HLE and pCI-hTERT-HLE in each plate were counted in triplicate every 24 h until pCI-hTERT-HLE cells reached 100% con¯uence in day 4 Figure 2 Overexpression of hTERT enhances RB hyperphosphorylation and E2F transactivity in pCI-hTERT-HLE Cells. (a) Determination of RB phosphorylation status in pCI-HLE, pCI-hTERT-HLE and 20 mM 5'-d(TTAGGG)-3'-treated pCI-hTERT-HLE (pCI-hTERT-HLE+1) through Western blot analysis. Western blot analysis was conducted as previously described. (Li et al., 1998; Xiang et al., 2000; Mao et al., 2001) . A 6% SDS ± PAGE was used to resolve the total protein. The anti-pRB antibody was purchased from Santa Cruz Biotechnology. RB-p: hyperphophorylated RB; RB: hypophosphorylated RB. (b) Western blot analysis of E2F-1 protein in pCI-HLE, pCI-hTERT-HLE and 20 mM 5'-d(TTAGGG)-3'-treated pCI-hTERT-HLE (pCI-hTERT-HLE+1). One hundred mg of total proteins extracted from the above cell samples were separated by 10% SDS ± PAGE, transferred to nitrocellulose membranes, probed with anti-E2F-1 speci®c antibody (Santa Cruz Biotechnology), then visualized with Amersham ECL kit. Note that there was only a small dierence in the level of the E2F-1 protein in the three dierent samples of cells. (c) E2F transactivity in pCI-HLE, pCI-hTERT-HLE and 20 mM 5'-d(TTAGGG)-3'-treated pCI-hTERT-HLE (pCI-hTERT-HLE+1). The E2F transactivity reporter plasmids pG5E1BCAT and E2CAT, and the control vector pRSV-b-Gal were described elsewhere (Wang et al., 1999; Xia et al., 2000; Xiang et al., 2000) . Protein extracts were prepared by three freezing ± thawing cycles. Equivalent amounts of cell lysates from each transfection were assayed for CAT activity with Quan-T-CAT assay system (Amersham International) as described in the manufacturer's manual. At the same time, aliquots of the same extracts were used to measure the b-galactosidase activity (Nielsen et al., 1983) . The net CAT activity of each sample was normalized against the b-galactosidase activity Oncogene Telomerase accelerates cell growth H Xiang et al Figure 3 hTERT-regulated expression of p53 and GCIP in pCI-HLE and pCI-hTERT-HLE, and demonstration that overexpression of GCIP counteracts hTERT-mediated growth acceleration. (a). Western Blot analysis of p53 was conducted as described in Figure 2b , the anti-p53 antibody was purchased from Santa Cruz Biotechnology. (b) Quantitation of the p53 protein blot. (c) Semi-quantitative RT ± PCR analysis of GCIP mRNA expression (top panel) and Western blot analysis of GCIP protein expression (bottom panel) in pCI-HLE and pCI-hTERT-HLE cells. The RT ± PCR procedure was described in Figure 1a . The primers used were 5'-CGAGAATTCATGGCGAGCGCAACTGCACC-3' (forward) and 5'-CGGGTCGACTCATAATTCAAGTT-CACTCTGAG-3' (reverse). The top 1.1 kb DNA band is derived from GCIP mRNA. The bottom is an internal control DNA band of 540-bp ampli®ed from the b-actin mRNA. Western blot analysis was described in Figure 2b . The anti-GCIP antibody was previously described (Xia et al., 2000) . (d). Quantitation of the RT ± PCR result (top panel) and the Western blot result (bottom panel) in (c). Note that the mRNA and protein levels for GCIP in pCI-hTERT-HLE cells is about fourfold and ®vefold lower than that in pCI-HLE cells respectively. (e) Overexpression of GCIP in pCI-hTERT-HLE cells. The human GCIP cDNA (Xia et al., 2000) was inserted into pEGFPC3 in frame. The construct was veri®ed by DNA sequencing, and the plasmid DNA was ampli®ed in DH-5a, then puri®ed by CsCl ultra-centrifugation as previously described . Both the vector, pEGFPC3, and the GCIP expression construct, pEGFPC3-GCIP, were introduced into pCI-hTERT-HLE cells using electroporation as described before (Xiang et al., 2000) . After 48 h, the transfected cells were either harvested for Western blot analysis shown in (e) or further plated in `free' E2F factors released from RB/E2F complex in pCI-hTERT-HLE, and thus the E2F transactivity would be increased. To test this possibility, we ®rst detected the E2F-1 protein level in these cells. As shown in Figure 2b , Western blot revealed that pCIhTERT-HLE cells had only a slightly higher level of E2F-1 protein than the pCI-HLE cells. Treatment of pCI-hTERT-HLE cells with the oligonucleotide inhibitor did not signi®cantly change the E2F-1 protein level. In contrast to the E2F-1 protein level observed in Figure 4 Overexpression of hTERT in human lens epithelial cells derived from primary cultures (HLEPC) also accelerates cell growth. (a) RT ± PCR to detect the mRNA expression of the hTERT. The RT ± PCR was conducted as described in Figure 1a . The DNA band of 309-bp (the bottom row) is ampli®ed from hTERT mRNA. The top is the internal control DNA band of 540-bp ampli®ed from the b-actin mRNA. (b) Assay of hTERT activity. TRAP assay was performed as described in Figure 1c . Note that the hTERT activity was observed only in pCI-hTERT-HLEPC cells (right lane) but not in pCI-HLEPC cells (middle lane) and HLEPC cells (left lane). (c) Analysis of growth rate of the HLEPC cells at the time when they were transfected (HLEPC-A) or undergone additional 10 population doublings (HLEPC-B) , and the vector-transfected HLEPC cells after 6-week selection (pCI-HLEPC) as well as established hTERT-transfected HLEPC cells after 25PDs (pCI-hTERT-HLEPC). The four types of cells were plated in six-well plates at 2.5610 4 cells per well. The media were replaced every 2 days, and the cells of pCI-hTERT-HLE and pCI-HLE in each plate were counted in triplicate every 24 h for a continuous 5 days. Note that the growth rate of pCI-hTERT-HLEPC is about 50% faster than that of the initial parental HLEPC (HLEPC-A). On the other hand, the HLEPC cells after additional 10 population doublings (HLEPC-B) , and the vector-transfected cells after their 6-week selection by G418 (pCI-HLEPC) have much slower growth rate 6-well plates in the presence of G418 for growth rate analysis as shown in (f). (f) Overexpression of GCIP in pCI-hTERT-HLE cells substantially counteracts the hTERT eect on cell growth. PCI-HLE, pCI-hTERT-HLE/pEGFP and pCI-hTERT-HLE/pEGFP-GCIP cells were plated in 6-well plates at 4610 4 cells per well. The media were replaced every 2 days, and the cells in each plate were counted in triplicate every 24 h until pCI-hTERT-HLE/pEGFP cells reached 100% con¯uence in day 5 these cells, the E2F transactivity in pCI-hTERT-HLE, pCI-HLE cells and inhibitor-treated pCI-hTERT-HLE cells were signi®cantly dierent when tested with E2F-CAT reporter system (E2CAT and pG5E1BCAT) (Figure 2c ). E2CAT vector contains the CAT gene driven by the adenovirus E2 promoter carrying two E2F binding sites (Wang et al., 1999) . Similarly, the plasmid pG5E1BCAT contains one E2F binding site in its promoter (Xia et al., 2000) . Twenty mg of E2F reporter plasmid together with 4 mg of pRSV-b-Gal vector were cotransfected into 1610 6 pCI-hTERT-HLE or pCI-HLE cells by electroporation. After 48 h of culture in the absence or presence of the telomerase inhibitor, equal amount of protein from each extract was used to measure CAT activity and b-galactosidase activity. As shown in Figure 2c , E2F transactivity in pCI-hTERT-HLE cells was clearly increased. With the pG5E1BCAT reporter system, the relative E2F transactivity in pCI-hTERT-HLE cells was increased to 1.8-fold than that in pCI-HLE cells. In E2CAT reporter system, the increase was up to 2.4-fold ( Figure  2c ). Inhibition of telomerase activity with the oligonucleotide not only attenuated RB hyperphosphorylation (Figure 2a ) but also downregulated the E2F transactivity in pCI-hTERT-HLE cells (Figure 2c) .
To explore the possible mechanisms mediating enhancement of RB hyperphosphorylation and upregulation of E2F transactivity in pCI-hTERT-HLE cells, we next asked whether the expression of the regulators of the RB/E2F pathway was also changed in pCI-hTERT-HLE compared with pCI-HLE cells. First, we examined the expression of p53 and p21 WAF1 with RT ± PCR and Western blot analysis. As shown in Figure 3a , b, p53 protein was downregulated about 2.2-fold in pCI-hTERT-HLE than that in pCI-HLE cells. There was little dierence observed regarding the p53 mRNA levels between pCI-hTERT-HLE and pCI-HLE cells (data not shown). For p21 WAF1 , while the mRNA was downregulated about 1.8-fold in the pCIhTERT-HLE than that in pCI-HLE cells (data not shown), the protein was only downregulated about 30% in the pCI-hTERT-HLE than that in pCI-HLE cells (data not shown). Next, we examined the expression of two other CDK inhibitors, p16 INK4C and p27 KIP1 , our results revealed little dierence between pCI-hTERT-HLE and pCI-HLE cells (data not shown). Finally, we analysed the expression of a recently cloned CDK regulator, GCIP. Previous work (Xia et al., 2000) revealed that GCIP could interact with cyclin D to inhibit CDK activity, and thus regulate E2F-mediated transactivity through RB pathway. In the pCI-hTERT-HLE, GCIP was clearly downregulated at the mRNA (about 3.6-fold) and protein (about 4.8-fold) levels (Figure 3c,d) . These results implicated that p53, p21, especially GCIP were involved in the enhancement of RB hyperphosphorylation and E2F transactivity, which likely accounted for hTERT-driven cell growth acceleration. To test this possibility, we have transiently overexpressed GCIP in pCI-hTERT-HLE cells. As shown in Figure 3e ,f, overexpression of GCIP in pCI-hTERT-HLE cells substantially counteracts the hTERT eect on acceleration of cell growth.
To further con®rm our observation that overexpression of hTERT in human lens epithelial cells accelerates cell growth, we have transfected telomerase-negative human lens epithelial cells derived from primary cultures of the donated human lenses (HLEPC) with hTERT cDNA expression construct or the vector alone. After selection with G418 (400 mg/ ml) for 6 weeks, the vector-and hTERT-transfected clones were established. The expression of hTERT in HLEPC was con®rmed by RT ± PCR (Figure 4a ) and TRAP assay (Figure 4b ). When the growth rate of these clones was compared with that of the initial parental HLEPC cells (HLEPC-A, these cells were in the same population doubling stage when they were used for transfection) or the HLEPC cells undergone additional 10 population doublings (HLEPC-B) , the hTERT-transfected HLEPC cells after 25 population doublings still had a 50% faster growth rate than the initial parental HLCPC (HLEPC-A). In contrast, the HLEPC cells undergone additional 10 PDs (HLEPC-B) and the vector-transfected HLEPC after G418 selection displayed much slower growth rate (Figure 4c) .
In summary, our data clearly demonstrated that besides its major role to maintain telomere stability, hTERT could also accelerate cell growth when it was overexpressed in the human lens epithelial cells. This increase of cell growth rate is apparently associated with the changed expression of dierent genes. First, overexpression of hTERT in the human lens epithelial cell line downregulated p53, and this downregulation occurred mainly at protein level (Figure 3a,b) . Associated with the downregulation of p53, p21 WAF1 was clearly downregulated in the mRNA level and slightly downregulated in the protein level in the pCI-hTERT-HLE cells (data not shown). Furthermore, overexpression of hTERT substantially downregulated expression of GCIP, another inhibitor for cyclin-CDK complexes (Xia et al., 2000) at both mRNA and protein levels. Since p21 WAF1 and GCIP are inhibitors of cyclin-CDK complexes and DNA replication (Xiong et al., 1993; El-Deiry et al., 1993; Waga et al., 1994; Xia et al., 2000) , downregulation of these molecules would allow the hTERT expression cells entering the cell cycle more quickly. This would be consistent with our observation that overexpression of GCIP in the pCIhTERT-HLE cells slows down their growth rate. As a result of downregulation of p21 WAF1 and GCIP in the hTERT-transfected HLE, RB protein was completely hyperphosphorylated in these cells (Figure 2a) . With RB hyperphosphorylation, E2F transactivity was clearly upregulated (Figure 2c ). Since E2F activity is one of the key regulators for S-phase entry (Dobrowolski et al., 1994; Sellers et al., 1995; Leone et al., 1998) , the observed upregulation of E2F activity in pCI-hTERT-HLE could promote the cell cycle progression. Taken together, our results demonstrate that by regulating expression of the genes mediating RB/E2F pathway and possibly other genes, hTERT can promote cell growth in human lens epithelial cells. To our knowledge, this is the ®rst report that telomerase aects cell growth rate. Of course, how hTERT regulates expression of other genes remains to be further investigated.
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